TAMPA, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)LIFELINK FOUNDATION INC, founded in 1982, is a major nonprofit in the Health Care sector that reported $205.8M in total revenue in fiscal year 2024. Revenue surged 23% from the prior year, signaling strong growth momentum. Expenses of $178.3M left a modest 13% surplus.
TO HONOR DONORS AND SAVE LIVES THROUGH ORGAN AND TISSUE DONATION. (EXPANDED MISSION ON SCHEDULE O)
LIFELINK FOUNDATION ORGAN PROCUREMENT ORGANIZATIONS: ORGAN DONATION IS ONE OF THE MOST MEANINGFUL, EMOTIONAL, AND VULNERABLE EXPERIENCES A FAMILY CAN FACE. OUR LONGSTANDING PRESENCE IN OUR DONOR...
LIFELINK FOUNDATION ORGAN PROCUREMENT ORGANIZATIONS: ORGAN DONATION IS ONE OF THE MOST MEANINGFUL, EMOTIONAL, AND VULNERABLE EXPERIENCES A FAMILY CAN FACE. OUR LONGSTANDING PRESENCE IN OUR DONOR SERVICE AREAS MEAN:- FAMILIES KNOW US- HOSPITALS RELY ON US- COMMUNITY PARTNERS VALUE OUR OUTREACH- OUR STAFF REFLECT THE COMMUNITIES THEY SERVE- TRANSPLANT CENTERS TRUST OUR EXPERTISE(CONTINUED ON SCHEDULE O)LIFELINK OF FLORIDA, LIFELINK OF GEORGIA, AND LIFELINK OF PUERTO RICO PARTNER WITH HOSPITALS TO PROVIDE RESOURCES AND COMFORT TO FAMILIES THROUGH THE PROCESS OF ORGAN DONATION IN 15 FLORIDA COUNTIES, THE STATE OF GEORGIA AND TWO COUNTIES IN SOUTH CAROLINA, AND THE COMMONWEALTHS OF PUERTO RICO AND US VIRGIN ISLANDS, RESPECTIVELY. THEY CARRY OUT THE DECISIONS OF REGISTERED DONORS AND THOSE FAMILIES WHO SAID "YES" TO DONATION AND HONOR THE LIFE OF EACH DONOR BY PROVIDING ORGANS FOR TRANSPLANT TO AS MANY PATIENTS AS POSSIBLE.THE ACT OF ORGAN DONATION GIVES PATIENTS WITH CRITICAL CONDITIONS A SECOND CHANCE AT LIFE. ONE ORGAN DONOR CAN SAVE 8 LIVES. THANKS TO A DONOR HERO'S LIFESAVING GIFTS, MANY TRANSPLANT RECIPIENTS GO ON TO LEAD NORMAL, ACTIVE AND PRODUCTIVE LIVES. THANKS TO THE GENEROSITY OF ORGAN DONORS AND THEIR FAMILIES, LIFELINK OF FLORIDA, LIFELINK OF GEORGIA AND LIFELINK OF PUERTO RICO FACILITATED 2,645 LIFE-SAVING ORGAN TRANSPLANTS DURING THE 2025 FISCAL YEAR, REPRESENTING OVER 5% OF ALL TRANSPLANTS PERFORMED IN THE UNITED STATES. EACH LIFELINK OPO CONTRIBUTED TO THESE EFFORTS, WITH LIFELINK OF FLORIDA FACILITATING RECOVERY OF 356 DONORS, LEADING TO 959 ORGANS BEING TRANSPLANTED. LIFELINK OF GEORGIA TRANSPLANTED 1,388 ORGANS FROM THE RECOVERY OF 446 DONORS. LIFELINK OF PUERTO RICO RECOVERED FROM 115 DONORS AND TRANSPLANTED 298 ORGANS. DONATION RESULTS FROM INTERNAL COLLABORATION, AS WELL AS COLLABORATION WITH PARTNER HOSPITALS AND THE COMMUNITY, IMPLEMENTATION AND EVALUATION OF PROCESS IMPROVEMENT, STAFF COMMITMENT TO EXCELLENCE, AND MOST OF ALL, DONOR FAMILY SUPPORT AND THE FORETHOUGHT OF INDIVIDUALS WHO CHOSE TO JOIN THEIR RESPECTIVE STATE DONOR REGISTRIES.AN EXAMPLE OF COLLABORATION WITH OUR PARTNER HOSPITALS HAS BEEN THE LIFELINK DONOR CARE UNIT AT PIEDMONT ATLANTA HOSPITAL. THE DONOR CARE UNIT ENHANCES THE LIFESAVING GIFTS PROVIDED BY GENEROUS ORGAN DONORS THROUGH EXPERT CLINICAL MANAGEMENT, WHILE CONTINUING TO SUPPORT DONOR FAMILIES THROUGH THE DONATION PROCESS WITH COMPASSIONATE, PERSONALIZED CARE. A SIMILAR CONCEPT OF DEDICATED SPACE HAS BEEN IMPLEMENTED AT TAMPA GENERAL HOSPITAL IN TAMPA, FLORIDA FOR OUR LIFELINK FLORIDA OPO AND AT AUXILLO MUTUO IN PUERTO RICO FOR OUR LIFELINK PUERTO RICO OPO. PARTNERSHIP WITH HOSPITALS DOES NOT END WITH ENGAGEMENT IN CLINICAL DONOR MANAGEMENT AND ORGAN RECOVERY. LIFELINK OPOS ALSO WORKED WITH 383 LOCAL HOSPITALS THROUGHOUT THE FOUNDATION SERVICE AREA TO CREATE A DONATION FRIENDLY COMMUNITY WITHIN HOSPITALS AND THE AREAS WE BOTH SERVE.
LIFELINK TISSUE BANK: LIFELINK TISSUE BANK IS A DEDICATED STEWARD OF THE LEGACY ENTRUSTED TO US BY TISSUE DONORS AND THEIR FAMILIES. WE HONOR EACH TISSUE DONOR BY SAFELY PROVIDING AN ENHANCED QUALITY...
LIFELINK TISSUE BANK: LIFELINK TISSUE BANK IS A DEDICATED STEWARD OF THE LEGACY ENTRUSTED TO US BY TISSUE DONORS AND THEIR FAMILIES. WE HONOR EACH TISSUE DONOR BY SAFELY PROVIDING AN ENHANCED QUALITY OF LIFE TO AS MANY PEOPLE AS POSSIBLE THROUGH TISSUE TRANSPLANTATION AND INNOVATIVE RESEARCH TO IMPROVE PATIENT CARE. (CONTINUED ON SCHEDULE O) GENEROUS TISSUE DONORS MADE POSSIBLE MORE THAN 83,000 MUSCULOSKELETAL TISSUE GRAFTS TO ENHANCE THE LIVES OF PATIENTS IN NEED OF TISSUE TRANSPLANTATION. ADDITIONALLY, THROUGH BIRTH TISSUE DONATION, THE ONLY DONATION LIFELINK FACILITATES FROM LIVING DONORS, NEARLY 45,000 GRAFTS WERE MADE AVAILABLE TO HELP PATIENTS RECOVER FROM DIFFICULT-TO-HEAL WOUNDS, DIABETIC ULCERS AND DURING OTHER LIFE ENHANCING SURGICAL PROCEDURES.TISSUES RECOVERED BY LIFELINK TISSUE BANK: SKIN: PRIMARILY USED TO ASSIST IN THE HEALING OF BURN PATIENTS BONE: USED FOR A VARIETY OF ORTHOPEDIC AND SPINAL PROCEDURES TENDONS: OFTEN USED ON SPORTS-RELATED INJURIES VALVES: USED COMMONLY IN HEART VALVE REPLACEMENT SURGERIES BIRTH TISSUE: PLACENTAL TISSUE DONATED BY NEW MOTHERS AFTER THE BIRTH OF THEIR BABY AND THE ONLY TISSUE RECOVERED AND PROCESSED BY LIFELINK TISSUE BANK FROM A LIVING DONOR, IS UTILIZED AS A WOUND COVERING. TISSUES PROCESSED AND DISTRIBUTED BY LIFELINK TISSUE BANK: SPINAL GRAFTS: DESIGNED TO PROMOTE FUSION AND HELP PATIENTS WHO SUFFER FROM SEVERE AND/OR CHRONIC PAIN TO LEAD NORMAL LIVES. SPORTS GRAFTS: USED IN JOINT RESTORATION PROCEDURES TO HELP RESTORE MOVEMENT TO PATIENTS SUFFERING FROM PAIN AND DISCOMFORT THAT PREVENTS THEM FROM ENJOYING ACTIVE LIFESTYLES. GENERAL ORTHOPEDIC GRAFTS: HELP TO PROMOTE BONE FORMATION, OPTIMIZE HEALING AND ACCELERATE A PATIENT'S RETURN TO NORMAL FUNCTION. FRESH AMNIOTIC BIRTH TISSUE TO TREAT DIABETIC FOOT ULCERS AND OTHER DIFFICULT TO CLOSE WOUNDS.
LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY: LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY BRINGS THE LEGACY ESTABLISHED BY ORGAN DONORS AND THEIR FAMILIES TO LIFE BY SERVING AS THE MATCHMAKER...
LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY: LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY BRINGS THE LEGACY ESTABLISHED BY ORGAN DONORS AND THEIR FAMILIES TO LIFE BY SERVING AS THE MATCHMAKER BETWEEN ORGAN DONORS AND POTENTIAL TRANSPLANT RECIPIENTS. WE CONTINUE TO HONOR DONORS BY ENSURING THE LONGEVITY OF RENEWED LIFE WITH DILIGENT POST-TRANSPLANT MONITORING AND INNOVATIVE RESEARCH TO IMPROVE PATIENT CARE. (CONTINUED ON SCHEDULE O)DURING THE 2025 FISCAL YEAR, THE LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY FACILITATED 1,062 LIFESAVING TRANSPLANTS FOR SIX TRANSPLANT CENTERS SERVED. THEY ALSO EVALUATED 545 LIVING DONORS AND 947 DECEASED DONORS AND CONDUCTED OVER 44,000 TRANSPLANT RELATED TESTS. THE LIFELINK TRANSPLANTATION IMMUNOLOGY LABORATORY UTILIZES HLA TYPING BY NEXT-GENERATION SEQUENCING (NGS) TO BETTER ASSESS THE COMPATIBILITY OF A DONOR AND A POTENTIAL RECIPIENT.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $205,771,733 | $167,670,624 | +0.2% |
| Expenses | $178,341,449 | $156,551,520 | +0.1% |
| Net Income | $27,430,284 | $11,119,104 | +1.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| STEPHANIE HERNANDEZ | PRESIDENT & CEO | 40.00 |
Officer
Director
|
$575,348 | $337,814 | $913,162 |
| VICTOR BOWERS MD | VICE CHAIR, MEDICAL DIRECTOR OPO | 40.00 |
Director
|
$375,604 | $72,842 | $448,446 |
| THOMAS PEARSON MD | DIRECTOR, MEDICAL DIRECTOR LLGA | 20.00 |
Director
|
$84,903 | $31,428 | $116,331 |
| JOEL VAN SICKLER MD | DIRECTOR, ASSOC MEDICAL DIR LLFL | 20.00 |
Director
|
$55,832 | $28,564 | $84,396 |
| ESTHER TORRES | DIRECTOR, MEDICAL DIRECTOR OPO PR | 20.00 |
Director
|
$79,389 | $30,691 | $110,080 |
| JEAN DAVIS | CHAIR (TERM END 5/2025) | 2.00 |
Officer
Director
|
$2,250 | $0 | $2,250 |
| HAROLD MULLIS JR ESQUIRE | DIRECTOR | 2.00 |
Director
|
$2,250 | $0 | $2,250 |
| JEFFREY L SEAVEY CFP | DIRECTOR | 2.00 |
Director
|
$1,500 | $0 | $1,500 |
| J DAVID VEGA MD | DIRECTOR | 2.00 |
Director
|
$1,500 | $0 | $1,500 |
| DEBORAH WINEGARD JD | DIRECTOR | 2.00 |
Director
|
$2,250 | $0 | $2,250 |
| JAMES J WYNN MD | DIRECTOR | 2.00 |
Director
|
$2,250 | $0 | $2,250 |
| WILLIAM CLEVELAND | DIRECTOR | 2.00 |
Director
|
$750 | $0 | $750 |
| DARA SIMON | DIRECTOR | 2.00 |
Director
|
$1,500 | $0 | $1,500 |
| CHRISTINA KLEIN | DIRECTOR | 2.00 |
Director
|
$1,500 | $0 | $1,500 |
| BENJAMIN JAMES | DIRECTOR | 2.00 |
Director
|
$1,500 | $0 | $1,500 |
| ARNOLD MIGNUCCI | DIRECTOR | 2.00 |
Director
|
$1,500 | $0 | $1,500 |
| MARTY SELLERS | DIRECTOR (TERM END 11/08/2024) | 2.00 |
Director
|
$1,500 | $0 | $1,500 |
| SHANNON HOLTHAUS | DIRECTOR | 2.00 |
Director
|
$2,250 | $0 | $2,250 |
| LARRY JONES | DIRECTOR | 2.00 |
Director
|
$2,250 | $0 | $2,250 |
| PATRICK BRISLEY | TREASURER & CFO | 40.00 |
Officer
|
$288,729 | $58,779 | $347,508 |
| THERESA DALY | EXEC DIR, OPO OPERATIONS | 40.00 |
Key Emp
|
$338,708 | $68,614 | $407,322 |
| SUSAN RABEL | VP EXEC DIRECTOR | 40.00 |
Key Emp
|
$262,162 | $55,312 | $317,474 |
| KATHERINE PAYNE | EXEC DIRECTOR LLGA (THRU 12/13/24) | 40.00 |
Key Emp
|
$259,817 | $38,472 | $298,289 |
| HOPE WEED | EXEC DIRECTOR LLGA | 40.00 |
Key Emp
|
$191,502 | $42,691 | $234,193 |
| GUILLERMINA SANCHEZ | EXEC DIRECTOR LLPR | 40.00 |
Key Emp
|
$187,368 | $42,893 | $230,261 |
| MICHAEL CONSILVIO | EXEC DIRECTOR GENERAL MGR | 40.00 |
Key Emp
|
$379,703 | $72,592 | $452,295 |
| JOHN LUNZ | EXEC DIRECTOR IMMUNOLOGY LAB | 40.00 |
Key Emp
|
$368,782 | $124,497 | $493,279 |
| JACENTHA BUGGS | ORGAN RECOVERY SURGEON | 40.00 |
Highest
|
$351,596 | $58,242 | $409,838 |
| MARK P STRONG | SR VP, ASSOC EXEC DIRECTOR | 40.00 |
Highest
|
$286,542 | $58,978 | $345,520 |
| HUSSEIN OSMAN MOHAMED | ORGAN RECOVERY SURGEON | 40.00 |
Highest
|
$283,684 | $48,983 | $332,667 |
| CATHERINE GEBHART | DIRECTOR, IMMUNOLOGY LAB | 40.00 |
Highest
|
$282,650 | $64,628 | $347,278 |
| BRAD BASSLER | VP OPS, ASSOC EXEC DIRECTOR | 40.00 |
Highest
|
$270,847 | $57,034 | $327,881 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $205,771,733 | $178,341,449 | $321,109,450 | $27,430,284 |
| 2024 | No data | No data | No data | No data |
| 2023 | $157,150,867 | $141,518,110 | $269,289,075 | $15,632,757 |
| 2022 | $160,897,844 | $126,670,198 | $242,859,727 | $34,227,646 |
| 2021 | $153,776,680 | $121,521,805 | $245,544,963 | $32,254,875 |
| 2020 | $128,986,501 | $110,107,282 | $183,482,726 | $18,879,219 |
| 2019 | $123,638,327 | $112,359,001 | $156,400,115 | $11,279,326 |
| 2018 | $113,339,853 | $105,199,135 | $144,813,986 | $8,140,718 |
Compare LIFELINK FOUNDATION INC with other nonprofits in Florida and across the country.